Profil
Yves L'Epine is currently the Chairman at Abarem SASU, Abalux SAS, and Mci Falco.
Previously, he served as the Chief Executive Officer at Guerbet SA from 2019 to 2020, Chairman & Chief Executive Officer at Takeda France SAS from 1999 to 2010, and Vice President-Established Products Division at Abbott Laboratories from 2010 to 2011.
Dr. L'Epine holds an MBA from INSEAD and a doctorate from Université de Paris 5 René Descartes.
Postes actifs de Yves L'Epine
Sociétés | Poste | Début |
---|---|---|
Abarem SASU | Chairman | - |
Abalux SAS | Chairman | - |
Mci Falco | Chairman | - |
Anciens postes connus de Yves L'Epine
Sociétés | Poste | Fin |
---|---|---|
GUERBET | Chief Executive Officer | 01/01/2020 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2011 |
Takeda France SAS
Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Chief Executive Officer | 01/01/2010 |
Formation de Yves L'Epine
INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
GUERBET | Health Technology |
Entreprise privées | 5 |
---|---|
Université de Paris 5 René Descartes | Consumer Services |
Abarem SASU | |
Abalux SAS | |
Mci Falco | |
Takeda France SAS
Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Health Technology |